Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart

Abstract In this paper, a fuzzy hierarchical optimization framework is proposed for identifying potential antiviral targets for treating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the heart. The proposed framework comprises four objectives for evaluating the eliminatio...

Full description

Bibliographic Details
Main Authors: Sz-Wei Chu, Feng-Sheng Wang
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Bioinformatics
Subjects:
Online Access:https://doi.org/10.1186/s12859-023-05487-7
_version_ 1797556111857942528
author Sz-Wei Chu
Feng-Sheng Wang
author_facet Sz-Wei Chu
Feng-Sheng Wang
author_sort Sz-Wei Chu
collection DOAJ
description Abstract In this paper, a fuzzy hierarchical optimization framework is proposed for identifying potential antiviral targets for treating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the heart. The proposed framework comprises four objectives for evaluating the elimination of viral biomass growth and the minimization of side effects during treatment. In the application of the framework, Dulbecco’s modified eagle medium (DMEM) and Ham’s medium were used as uptake nutrients on an antiviral target discovery platform. The prediction results from the framework reveal that most of the antiviral enzymes in the aforementioned media are involved in fatty acid metabolism and amino acid metabolism. However, six enzymes involved in cholesterol biosynthesis in Ham’s medium and three enzymes involved in glycolysis in DMEM are unable to eliminate the growth of the SARS-CoV-2 biomass. Three enzymes involved in glycolysis, namely BPGM, GAPDH, and ENO1, in DMEM combine with the supplemental uptake of L-cysteine to increase the cell viability grade and metabolic deviation grade. Moreover, six enzymes involved in cholesterol biosynthesis reduce and fail to reduce viral biomass growth in a culture medium if a cholesterol uptake reaction does not occur and occurs in this medium, respectively.
first_indexed 2024-03-10T16:57:09Z
format Article
id doaj.art-b02546b04af84067b600a60984251bcb
institution Directory Open Access Journal
issn 1471-2105
language English
last_indexed 2024-03-10T16:57:09Z
publishDate 2023-09-01
publisher BMC
record_format Article
series BMC Bioinformatics
spelling doaj.art-b02546b04af84067b600a60984251bcb2023-11-20T11:06:09ZengBMCBMC Bioinformatics1471-21052023-09-0124112510.1186/s12859-023-05487-7Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heartSz-Wei Chu0Feng-Sheng Wang1Department of Chemical Engineering, National Chung Cheng UniversityDepartment of Chemical Engineering, National Chung Cheng UniversityAbstract In this paper, a fuzzy hierarchical optimization framework is proposed for identifying potential antiviral targets for treating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the heart. The proposed framework comprises four objectives for evaluating the elimination of viral biomass growth and the minimization of side effects during treatment. In the application of the framework, Dulbecco’s modified eagle medium (DMEM) and Ham’s medium were used as uptake nutrients on an antiviral target discovery platform. The prediction results from the framework reveal that most of the antiviral enzymes in the aforementioned media are involved in fatty acid metabolism and amino acid metabolism. However, six enzymes involved in cholesterol biosynthesis in Ham’s medium and three enzymes involved in glycolysis in DMEM are unable to eliminate the growth of the SARS-CoV-2 biomass. Three enzymes involved in glycolysis, namely BPGM, GAPDH, and ENO1, in DMEM combine with the supplemental uptake of L-cysteine to increase the cell viability grade and metabolic deviation grade. Moreover, six enzymes involved in cholesterol biosynthesis reduce and fail to reduce viral biomass growth in a culture medium if a cholesterol uptake reaction does not occur and occurs in this medium, respectively.https://doi.org/10.1186/s12859-023-05487-7Flux balance analysisGenome-scale metabolic modelConstraint-based modelingDrug discoveryHybrid differential evolutionMulti-level optimization
spellingShingle Sz-Wei Chu
Feng-Sheng Wang
Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart
BMC Bioinformatics
Flux balance analysis
Genome-scale metabolic model
Constraint-based modeling
Drug discovery
Hybrid differential evolution
Multi-level optimization
title Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart
title_full Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart
title_fullStr Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart
title_full_unstemmed Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart
title_short Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart
title_sort fuzzy optimization for identifying antiviral targets for treating sars cov 2 infection in the heart
topic Flux balance analysis
Genome-scale metabolic model
Constraint-based modeling
Drug discovery
Hybrid differential evolution
Multi-level optimization
url https://doi.org/10.1186/s12859-023-05487-7
work_keys_str_mv AT szweichu fuzzyoptimizationforidentifyingantiviraltargetsfortreatingsarscov2infectionintheheart
AT fengshengwang fuzzyoptimizationforidentifyingantiviraltargetsfortreatingsarscov2infectionintheheart